Renal Cell Carcinoma

Filter By:
30:57
Dr. Islam Shahin, Interventional Radiologist at Methodist Dallas Medical Center, discusses a multidisciplina​ry approach to treating liver tumors and the importance of a team approach.
by:SayYEStoHOPE | 75 views
20:59
Dr. James Brugarolas, M.D., Ph.D. Kidney Cancer Program Leader Associate Professor of Internal Medicine & Developmental Biology University of Texas Southwestern Medical Center discusses RCC Classification at the Kidney Cancer meeting in Chicago
by:kidneycancer | 71 views
04:37
Dr. Hiral D. Parekh, M.D. discusses Cost Analysis of an Initial Observation Approach in Metastatic Renal Cell Carcinoma at the Kidney Cancer meeting in Chicago
by:kidneycancer | 54 views
04:44
Dr. Laurence Albiges, M.D., Ph.D. discusses Differential expression of c-MET between primary and metastatic sites in clear cell Renal Cell Carcinomas (ccRCCs) at the Kidney Cancer meeting in Chicago.
by:kidneycancer | 65 views
04:30
Dr. Andre P. Fay, M.D. discusses Whole-Exome Sequencing Predicting Two Extreme Phenotypes of Response to VEGF-targeted Therapies in Patients with Metastatic Clear Cell Renal Cell Carcinoma (mRCC) at the Kidney Cancer meeting in Chicago
by:kidneycancer | 71 views
16:54
Dr. Joshua Lang, M.D., M.S. discusses Development of Pharmacodynamic Biomarkers in Circulating Renal Cancer Cells at the Kidney Cancer meeting in Chicago
by:kidneycancer | 61 views
13:18
Dr. Harriet Kluger, M.D.Associate Professor Yale Cancer Center discusses The Met Pathway as a Target in RCC at the Kidney Cancer meeting in Chicago
by:kidneycancer | 37 views
05:04
Dr. David F. McDermott discusses Immune correlates and long-term follow-up of a Phase Ia study of MPDL3280A, an engineered PD-L1 antibody, in patients with metastatic renal cell carcinoma (mRCC) at the Kidney Cancer meeting in Chicago
by:kidneycancer | 62 views
16:17
Dr. Thai Ho, M.D., Ph.D.Mayo Clinic Arizona discusses The Evolving Role of Chromatin and Epigenetics in RCC at the Kidney Cancer meeting in Chicago
by:kidneycancer | 25 views
05:55
Dr. Toni K. Choueiri discusses Risk Factors and a Model to Predict Toxicity-relate​d Treatment Discontinuation in Patients with Metastatic Renal Cell Carcinoma (mRCC) Treated with Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy: Results from the International Metastatic RCC Database Consor...
by:kidneycancer | 70 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)